KOREAN RED GINSENG HERITAGE Singapore - English - HSA (Health Sciences Authority)

korean red ginseng heritage

union chemical & pharmaceutical (pte) ltd - capsules

Oxehab Solution For Injection Philippines - English - FDA (Food And Drug Administration)

oxehab solution for injection

union korea pharm co., ltd.; importer: h & b pharma international inc.; distributor: h & b pharma international inc. - iohexol - solution for injection - 350 mg/ml solution for injection (equivalent to 755 mg of lohexol)

Ausfotaxime 1g Powder For Injection (IM/IV) Philippines - English - FDA (Food And Drug Administration)

ausfotaxime 1g powder for injection (im/iv)

auskorea pharm. co., ltd.; importer: jlt pharma inc.; distributor: jlt pharma inc. - cefotaxime (as sodium) - powder for injection (im/iv) - 1g

Apixaban Combino Pharm 2.5 mg film-coated tablets Malta - English - Medicines Authority

apixaban combino pharm 2.5 mg film-coated tablets

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Apixaban Combino Pharm 5 mg film-coated tablets Malta - English - Medicines Authority

apixaban combino pharm 5 mg film-coated tablets

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 5 mg - antithrombotic agents

Florexa Cream 13.9% Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

florexa cream 13.9%

بيلا للصناعات الدوائية - pella pharmaceuticals co.ltd - eflornithine hydrochloride 13.9 % - 13.9%

Spotex 4% Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

spotex 4%

بيلا للصناعات الدوائية - pella pharmaceuticals co.ltd - erythromycin 4 % - 4%

Granisetron 1mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 1mg tablets

torrent pharma (uk) ltd - granisetron hydrochloride - oral tablet - 1mg

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).